Q2 FY27 earnings call · November 16, 2026
Indo-MIM Ltd (INDOMIM) Q2 FY27 Earnings Call: Guides Rs. 5,000 Cr Revenue Comfortably, IGT Demand Booming For Next Decade
Listen to the earnings call
Quick summary
Indo-MIM Ltd held its Q2 FY27 earnings call on November 13, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.
Sequential Revenue Growth, Flat Underlying Profit
- Q2 FY 2026-2027 revenue of Rs.1,271 crore — up from Rs.1,218 crore in Q1 FY 2026-2027 and above the year-ago quarter; profit before exceptional items was Rs.309 crore vs Rs.325 crore in Q1 (CFO).
- H1 FY 2026-2027 consolidated revenue of Rs.2,490 crore — up Rs.263 crore YoY; PAT of Rs.455 crore was up Rs.165 crore, but excluding exceptional items profit was broadly flat, about 1.5% higher.
- Standalone H1 revenue of Rs.2,073 crore — standalone PAT Rs.443 crore; IndoMIM Inc. contributed Rs.52 crore of PAT. Subsidiaries other than IndoMIM Inc. remain marginally loss-making.
- ROCE of 36.5%, up 5.7 pp — ROE 26.3% (up 3.4 pp); debt-to-equity fell to 0.27 from 0.5, net debt/EBITDA at 0.19, total debt Rs.941 crore vs Rs.1,255 crore a year ago.
- Working capital stretched — receivable days 64, inventory days 441 (up from 340), payable days 88; cash conversion cycle of 417 days is expected to fall by end of FY 2026-2027.
- About 80% of business is exports — average transit time 15-30 days and average customer credit period of about 45 days.
FY27 Top Line Comfortable; Bottom Line Hedged to January
- FY 2026-2027 top-line target of Rs.5,000 crore expected to be met comfortably — the Rs.850 crore bottom-line target is expected to be "perhaps marginally" met, later described as "slightly ahead"; firm bottom-line assurance only at the end of Q3 FY 2026-2027.
- CFO declined to confirm ~Rs.900 crore FY 2026-2027 bottom line — said guidance will be updated in January 2027; margin guidance also due in January.
- Q2 gross margin expansion attributed entirely to component mix — no raw material price increase and broadly stable forex; CEO added slightly better operational leverage also contributed.
- H2 margin pressure flagged — raw material consumption per unit is much higher as heavier components are made, lowering margin as a percentage of sales; margins vary by component complexity even within segments.
- Tri-X guided at $32-35 million top line for FY 2026-2027 — expected close to EBITDA neutral at that level; priority is first achieving cash flow positive.
- Other income in FY 2026-2027 expected slightly lower than FY 2025-2026 — prior year included clay refunds due from government agencies and forex differences; the Q2 balance is expected to double by end of FY 2026-2027.
Aerospace, Consumer and BPG Lead; ECM Weak
- H1 FY 2026-2027 mix: NIM ~60% of turnover — casting 19%, machining 8%, powders 1%, others 11-12%.
- Aerospace grew 31.5% (9% of business) — automotive grew 19.4% (25%), consumer grew 46.5% (16%), BPG grew 19.3% (20%) in H1 FY 2026-2027.
- Electronic component manufacturing fell ~40%, now 11% of business — FY 2026-2027 target of Rs.480-500 crore against Rs.268 crore achieved in H1, with roughly the same amount expected in H2; revenue ~Rs.40 crore lower than FY 2025-2026.
- Smartphone MIM programs rising but not yet in revenue — customer caused a delay in India MIM component start; outlook clearer by Q4 FY 2026-2027 when tool orders show; segment expected "on budget or a little bit below" in FY 2026-2027, setting up "a very strong fiscal 28."
- Medical is the highest-margin segment — CFO called it a lifestyle business, but cautioned higher medical revenue does not necessarily mean higher margin; segment margins will not be disclosed, only half-yearly segment revenue.
- Vietnam subsidiary expected to generate revenue in FY 2027-2028 — linked to the electronic component manufacturing segment; client name declined; development work there is expected to push up India business.
IGT "Booming"; Defense Ramp Awaits Government Orders
- Zero cancellations in IGT despite SoftBank's reported GE order cancellations — CEO said customers are instead "pulling in" work; GE is not the only IGT customer, with other gas turbine OEMs holding "very good order book[s]."
- IGT demand expected "booming... for the next decade to 15 years" — driven by data center generation requirements; aerospace growth "penciled in over the next 10 years" tied to engines sold to Southeast Asia.
- IGT ramp-up not yet visible in India's numbers — many programs won over the past year and a half will take time to translate into production; Tri-X programs were underdeveloped entering production but should reach profitability "fairly soon."
- Defense expected to grow significantly over FY 2027-2028 to FY 2028-2029 — CFO cited "about 30 companies have been licensed to manufacture small arms" in India; INDO-MIM supplies most licensees and awaits government orders, with defense additions recognized only on order receipt.
- European defense spending only now starting to flow through — CEO said the European defense market will take a couple of years (FY 2027-2028 to FY 2028-2029) to mature; US defense business robust and growing.
- European OEMs making room for military programs — companies including Safran are sourcing more business overseas across civilian aerospace and drone components; further Safran business depends on first executing current contracts.
- 1,200 aerospace components currently made — targeting an increase of at least 400 components in FY 2026-2027; civilian aerospace programs typically start with 4-5 parts, with the next package following 6 months to a year of shipments.
Emerging Applications Active but Unquantified
- Humanoid robotics opportunity unquantified — CEO said the company "can't give an exact number" but MIM components are being developed with all the major players; if customer volume projections hold, volumes "are going to be very significant."
- CFO called industry-player volume figures "very high" — even 10% of those figures (period unspecified) would make a "superlative year" for suppliers, and INDO-MIM would not be different.
- Opportunity extends beyond MIM to MIM plus machining — additional machining discussions described as significant with "quite large" volumes; space applications span MIM, castings and machining across the group.
- Better update promised in January on FY 2027-2028 impact — CEO said the company will provide a "better update in January on its impact in fiscal 28" for humanoid and space opportunities.
- Iron powder facility of ~3,000 tons per annum being set up (period unspecified) — ~1,500-2,000 tons needed for expanded requirements, leaving ~1,000-1,500 tons for sale; stainless steel powder backward integration already complete for captive use.
- Powder profitability excludes any cost advantage — operating leverage expected only once utilisation reaches about 70-80% (period unspecified).
Capex Focused on Machining; Europe M&A Within 12-18 Months
- No major capex planned for primary processes in FY 2026-2027 — capacity is ample in MIM and casting; FY 2026-2027 capex directed at secondary operations such as machining to support programs ramping over Q3 and Q4 FY 2026-2027; no specific capex figure given ("Numbers exactly are coming in now").
- Europe M&A targeted within the next 12 to 18 months (roughly FY 2027-2028) — Chairman wants "boots on the ground" (manufacturing in Europe for Europe); targets in the gas turbine supply chain and vacuum casting, including Tri-X and Tirupati, at deal sizes of about $20-50 million; he said there is "every chance" the company may not be able to buy them.
- Greenfield European start-up is the fallback — if acquisitions do not close, AJ is already preparing an organic plan; no closing timeframe given. US targets being evaluated by investment bankers, not yet approached; more guidance possible "in the middle of next year, early next year."
- No acquisitions planned in India — Singapore is being considered for MIM acquisitions to consolidate the market and gain pricing efficiencies "down the road"; possible future presence in Vietnam and Singapore ("quite possibly").
- Chairman expects organic growth "excellent in the next 3, 4, 5 years" — with inorganic acquisitions intended to compound value via an arbitrage of acquiring European and US technology and bringing it to India.
- Customers preparing now for 2029-2030 demand — in aerospace, IGT, space and humanoid applications, long IGT equipment lead times mean suppliers are onboarding parts now; FY 2027-2028 guidance will be given in February 2027 when the budget is drawn.
- CFO declined to quantify 2-3 year growth outlook — only opportunities that have "hatched" (sample developed and order placed) are counted; customers are "chasing the suppliers" in some industries, but supplier gains should not be extrapolated from customer-stated volumes.
Ask about this
Ask Cofacto a question about this call. Answers cite filings and company data.
Companies on this page
Related
Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.